Results 41 to 50 of about 6,033 (178)
Ultrasound renal denervation: the future of hypertension management?
Background Hypertension, a leading cause of global mortality and morbidity, affects approximately 1.28 billion adults worldwide, with most cases occurring in low- and middle-income countries.
Laiba Ali +5 more
doaj +1 more source
Effect of renal denervation on glucose metabolism after a 12 month follow-up
Background: Renal denervation is an invasive endovascular procedure using radiofrequency ablation of the renal arteries. This reduces renal sympathetic activity. However, the effect of renal denervation on glucose metabolism remains unclear.
Daniel Matous +3 more
doaj +1 more source
ABSTRACT Background The F64L variant is among the most frequent TTR mutations in Italy, typically associated with a predominantly neurologic phenotype and limited cardiac involvement. Methods Data from 181 ATTRv patients in the multicenter Patisiranitaly database treated with Patisiran since 2020 were analyzed. Neurologic impairment scores, Norfolk QoL‐
Marco Ceccanti +53 more
wiley +1 more source
A Clinician’s Perspective of Renal Sympathetic Nerve Contribution to Hypertension
The renal sympathetic nerves have a significant contribution to the control of different aspects of kidney function and blood pressure. Early animal studies of renal denervation (RDN) in a large number of different models of hypertension showed that RDN ...
Alexandros eBriasoulis +1 more
doaj +1 more source
Renal Sympathetic Denervation for Treating Resistant Hypertension
Systemic hypertension represents a significant global concern, because it contributes to vascular and renal morbidity, cardiovascular mortality, and economic burden, hence the impact of hypertension is a major issue in public health worldwide. Improving high blood pressure management is therefore fundamental to influencing clinical outcomes.
Polimeni, A., Curcio, A., Indolf, C.
openaire +4 more sources
Adverse Drug Reaction Study of Botulinum Toxin‐A in the Real World
ABSTRACT Background Despite the increasing use of botulinum toxin type A (BoNT‐A) in aesthetic and therapeutic applications, its real‐world adverse drug reaction (ADR) profile remains incompletely characterized. Current evidence relies largely on small‐scale clinical observations rather than large, systematic analyses.
Jiaxu Gu +9 more
wiley +1 more source
Phenol Neurolysis in Pain and Palliative Medicine
ABSTRACT Background Pain is a common symptom in palliative care and affects patients' quality of life considerably. Standard analgesics are sometimes insufficient and are associated with substantial side effects. Neurolysis, the targeted destruction of nerves using thermal or chemical agents, offers an additional option for managing localized pain in ...
Jeroen H. A. Creemers +6 more
wiley +1 more source
Background Renal denervation has no validated marker of procedural success. We hypothesized that successful renal denervation would reduce renal sympathetic nerve signaling demonstrated by attenuation of α‐1‐adrenoceptor‐mediated autotransfusion during ...
Manish Saxena +15 more
doaj +1 more source
Background. Hypertension contributes to the progression of cardiac remodeling and renal damage. In turn, renal sympathetic hyperactivation showed elevated sympathetic nervous system activity and led to blood pressure increase in certain patients.
Demin Liu +6 more
doaj +1 more source
Evaluation of cardiovascular parameters and renal mediators during the development of arterial hypertension in male DOCA‐Salt rats. Abstract Although renal dysfunction is present in arterial hypertension, the mechanisms underlying renal glomerular and tubular alterations remain incompletely understood.
Edina Da Luz Abreu +9 more
wiley +1 more source

